Recursion has rapidly established itself as a leader in the field of AI-enabled biotechnology. The company's BioHive-2 ...

Dr. Doberstein joins a distinguished group of board members with deep expertise in biotechnology, AI-driven drug discovery, and clinical development, further strengthening Invea’s leadership as it ...

Biomedicines, a Flagship Pioneering company leading in AI-enabled protein therapeutics discovery and development ...

November 2024 has seen a variety of biotech deals take place to advance therapies across different stages in development.

Technologies should be designed to serve the greater good, promoting fairness, transparency, and positive impact for the ...

Introduction: Recent advances in machine learning provide ... in developing predictive medicine algorithms, so there is definitely an emerging need for effective processing methodology. We believe ...

Dr. Nader currently serves as an Independent Board Director at Moderna and Ring Therapeutics, and Senior Advisor at Blackstone Life Sciences. Dr. Nader is the Chairman of BioLink.org and serves on the ...

One of the most common blood tests in the world, CBC tests are run billions of times each year, can be imprecise. Experts are ...

Enveda’s pipeline is led by ENV-294, a first-in-class, oral small molecule being developed to treat atopic dermatitis and other inflammatory conditions by combining the advantages of blockbuster drugs ...

She completed a residency in internal medicine and a ... along with insights from machine learning and AI, Cartography is identifying and developing therapeutics against highly specific targets and ...

Machine learning tools can increase the pace of biology research and open the door to new research questions, but the ...